Exact Mass: 430.218
Exact Mass Matches: 430.218
Found 340 metabolites which its exact mass value is equals to given mass value 430.218
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
1-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-glycero-3-phosphate
1-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-glycero-3-phosphate is classified as a member of the 1-acylglycerol-3-phosphates. 1-acylglycerol-3-phosphates are lysophosphatidic acids where the glycerol is esterified with a fatty acid at O-1 position. 1-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-glycero-3-phosphate is a glycerophosphate lipid molecule
LysoPA(18:4(6Z,9Z,12Z,15Z)/0:0)
LysoPA(18:4(6Z,9Z,12Z,15Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(18:4(6Z,9Z,12Z,15Z)/0:0), in particular, consists of one chain of stearidonic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
Sonchuside I
Sonchuside H
THYMOLPHTHALEIN
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D010635 - Phenolphthaleins D004396 - Coloring Agents
9,10,12,16,18-pentamethoxy-5,16-cyclo-17-nor-corynox-19-en-2-one
2-O-beta-D-glucopyranosyl-11alpha,13-dihydro-8-epi-desacetylxanthiuminol
1L-myo-inositol 2alpha,4beta-dimethylbutyryl 6beta-senecioyl 1(axial)beta,3alpha,5alpha
(3S)-3-O-(3,4-Diangeloyl-??-D-glucopyranosyloxy)-7-hydroperoxy-3,7-dimethylocta-1,5-diene
(1R,7R,8S,10R)-7,8,11-trihydroxyguai-4-en-3-one-8-O-beta-D-glucopyranoside
1beta-O-beta-D-glucopyranosyl-4beta-hydroxyl-5alpha,6beta,11betaH-eudesma-12,6alpha-olide
methyl (2beta,12beta,19alpha)-1-benzoylaspidospermidin-21-oate|N1-benzoyl-12-demethoxycylindrocarine
1-O-(2?,3?,4?,4?-tetrahydroabscisoyl)-beta-glucopyranose
rel-2R,5S,9S,10R,11R,12-trihydroxy-6(7)-spirovetiven-8-one-9-O-beta-D-glucopyranoside
17-hydroxy-9,10,12,18-tetramethoxy-5,16-cyclo-corynox-19-en-2-one
1L-myo-inositol 2alpha-isobutyryl 4beta-methylbutyryl 6beta-senecioyl 1(axial)beta,3alpha,5alpha
10,11-dimethoxy-19alpha-methyl-2-oxo-16,17-dihydro-(7alphaC2)-formosanane-16beta-carboxylic acid methyl ester|Herbalin|herbaline
4-O-beta-D-glucopyranosyl-11alpha,13-dihydro-8-epi-desacetylxanthiuminol
(1beta,7beta,8beta,10beta)-1,8,11-trihydroxy-4-guaien-3-one 11-O-beta-D-glucopyranoside|1beta-hydroxytorilolone 11-O-beta-D-glucopyranoside
4alpha(15),11beta(13)-tetrahydroridentin B-1-O-beta-glucopyranoside
C21H34O9_2(1H)-Azulenone, 6-(beta-D-glucopyranosyloxy)-4,5,6,7,8,8a-hexahydro-5-hydroxy-5-(1-hydroxy-1-methylethyl)-3,8-dimethyl
Ala Phe Pro Pro
Ala Ile Met Pro
Ala Ile Asn Asn
Ala Ile Pro Met
Ala Leu Met Pro
Ala Leu Asn Asn
Ala Leu Pro Met
Ala Met Ile Pro
Ala Met Leu Pro
Ala Met Pro Ile
Ala Met Pro Leu
Ala Asn Ile Asn
Ala Asn Leu Asn
Ala Asn Asn Ile
Ala Asn Asn Leu
Ala Asn Gln Val
Ala Asn Val Gln
Ala Pro Phe Pro
Ala Pro Ile Met
Ala Pro Leu Met
Ala Pro Met Ile
Ala Pro Met Leu
Ala Pro Pro Phe
Ala Gln Asn Val
Ala Gln Val Asn
Ala Val Asn Gln
Ala Val Gln Asn
Cys Ile Pro Val
Cys Ile Val Pro
Cys Leu Pro Val
Cys Leu Val Pro
Cys Pro Ile Val
Cys Pro Leu Val
Cys Pro Val Ile
Cys Pro Val Leu
Cys Val Ile Pro
Cys Val Leu Pro
Cys Val Pro Ile
Cys Val Pro Leu
Phe Ala Pro Pro
Phe Pro Ala Pro
Phe Pro Pro Ala
Gly Ile Asn Gln
Gly Ile Gln Asn
Gly Leu Asn Gln
Gly Leu Gln Asn
Gly Asn Ile Gln
Gly Asn Leu Gln
Gly Asn Gln Ile
Gly Asn Gln Leu
Gly Gln Ile Asn
Gly Gln Leu Asn
Gly Gln Asn Ile
Gly Gln Asn Leu
Gly Gln Gln Val
Gly Gln Val Gln
Gly Val Gln Gln
Ile Ala Met Pro
Ile Ala Asn Asn
Ile Ala Pro Met
Ile Cys Pro Val
Ile Cys Val Pro
Ile Gly Asn Gln
Ile Gly Gln Asn
Ile Met Ala Pro
Ile Met Pro Ala
Ile Asn Ala Asn
Ile Asn Gly Gln
Ile Asn Asn Ala
Ile Asn Gln Gly
Ile Pro Ala Met
Ile Pro Cys Val
Ile Pro Met Ala
Ile Pro Val Cys
Ile Gln Gly Asn
Ile Gln Asn Gly
Ile Val Cys Pro
Ile Val Pro Cys
Leu Ala Met Pro
Leu Ala Asn Asn
Leu Ala Pro Met
Leu Cys Pro Val
Leu Cys Val Pro
Leu Gly Asn Gln
Leu Gly Gln Asn
Leu Met Ala Pro
Leu Met Pro Ala
Leu Asn Ala Asn
Leu Asn Gly Gln
Leu Asn Asn Ala
Leu Asn Gln Gly
Leu Pro Ala Met
Leu Pro Cys Val
Leu Pro Met Ala
Leu Pro Val Cys
Leu Gln Gly Asn
Leu Gln Asn Gly
Leu Val Cys Pro
Leu Val Pro Cys
Met Ala Ile Pro
Met Ala Leu Pro
Met Ala Pro Ile
Met Ala Pro Leu
Met Ile Ala Pro
Met Ile Pro Ala
Met Leu Ala Pro
Met Leu Pro Ala
Met Pro Ala Ile
Met Pro Ala Leu
Met Pro Ile Ala
Met Pro Leu Ala
Asn Ala Ile Asn
Asn Ala Leu Asn
Asn Ala Asn Ile
Asn Ala Asn Leu
Asn Ala Gln Val
Asn Ala Val Gln
Asn Gly Ile Gln
Asn Gly Leu Gln
Asn Gly Gln Ile
Asn Gly Gln Leu
Asn Ile Ala Asn
Asn Ile Gly Gln
Asn Ile Asn Ala
Asn Ile Gln Gly
Asn Leu Ala Asn
Asn Leu Gly Gln
Asn Leu Asn Ala
Asn Leu Gln Gly
Asn Asn Ala Ile
Asn Asn Ala Leu
Asn Asn Ile Ala
Asn Asn Leu Ala
Asn Gln Ala Val
Asn Gln Gly Ile
Asn Gln Gly Leu
Asn Gln Ile Gly
Asn Gln Leu Gly
Asn Gln Val Ala
Asn Val Ala Gln
Asn Val Gln Ala
Pro Ala Phe Pro
Pro Ala Ile Met
Pro Ala Leu Met
Pro Ala Met Ile
Pro Ala Met Leu
Pro Ala Pro Phe
Pro Cys Ile Val
Pro Cys Leu Val
Pro Cys Val Ile
Pro Cys Val Leu
Pro Phe Ala Pro
Pro Phe Pro Ala
Pro Ile Ala Met
Pro Ile Cys Val
Pro Ile Met Ala
Pro Ile Val Cys
Pro Leu Ala Met
Pro Leu Cys Val
Pro Leu Met Ala
Pro Leu Val Cys
Pro Met Ala Ile
Pro Met Ala Leu
Pro Met Ile Ala
Pro Met Leu Ala
Pro Pro Ala Phe
Pro Pro Phe Ala
Pro Val Cys Ile
Pro Val Cys Leu
Pro Val Ile Cys
Pro Val Leu Cys
Gln Ala Asn Val
Gln Ala Val Asn
Gln Gly Ile Asn
Gln Gly Leu Asn
Gln Gly Asn Ile
Gln Gly Asn Leu
Gln Gly Gln Val
Gln Gly Val Gln
Gln Ile Gly Asn
Gln Ile Asn Gly
Gln Leu Gly Asn
Gln Leu Asn Gly
Gln Asn Ala Val
Gln Asn Gly Ile
Gln Asn Gly Leu
Gln Asn Ile Gly
Gln Asn Leu Gly
Gln Asn Val Ala
Gln Gln Gly Val
Gln Gln Val Gly
Gln Val Ala Asn
Gln Val Gly Gln
Gln Val Asn Ala
Gln Val Gln Gly
Val Ala Asn Gln
Val Ala Gln Asn
Val Cys Ile Pro
Val Cys Leu Pro
Val Cys Pro Ile
Val Cys Pro Leu
Val Gly Gln Gln
Val Ile Cys Pro
Val Ile Pro Cys
Val Leu Cys Pro
Val Leu Pro Cys
Val Asn Ala Gln
Val Asn Gln Ala
Val Pro Cys Ile
Val Pro Cys Leu
Val Pro Ile Cys
Val Pro Leu Cys
Val Gln Ala Asn
Val Gln Gly Gln
Val Gln Asn Ala
Val Gln Gln Gly
9-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-10-naphthalen-2-ylanthracene
4,4,5,5-tetraMethyl-2-(3-(triphenylen-2-yl)phenyl)-1,3,2-dioxaborolane
4,4,5,5-tetramethyl-2-(10-(naphthalen-1-yl)anthracen-9-yl)-1,3,2-dioxaborolane
bis-(2,2,6,6-Tetramethyl-3,5-heptanedionato)oxotitanium(IV)
2-((4-(4-Hydroxypiperidin-1-Yl)phenyl)amino)-5,11-Dimethyl-5h-Benzo[e]pyrimido [5,4-B][1,4]diazepin-6(11h)-One
5-hydroxy-5-(2-hydroxypropan-2-yl)-3,8-dimethyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4,6,7,8,8a-hexahydroazulen-2-one
[1-[(1,2-Dimethyl-3-indolyl)methyl]-4-[[3-(trifluoromethyl)phenyl]methyl]-4-piperidinyl]methanol
[(3aS,4S,9bS)-4-(hydroxymethyl)-8-[2-(4-methoxyphenyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-cyclopentylmethanone
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-1,2-oxazole-3-carboxamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-1,2-oxazole-3-carboxamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-1,2-oxazole-3-carboxamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
1-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-glycero-3-phosphate
1-Linoleoylglycerone 3-phosphate(2-)
A 1-acylglycerone 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-linoleoylglycerone 3-phosphate; major species at pH 7.3.
gamma-Linolenoyl-sn-glycero-3-phosphate(2-)
A 1-acyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of gamma-linolenoyl-sn-glycero-3-phosphate.
1-Linolenoyl-sn-glycero-3-phosphate(2-)
A 1-acyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-linolenoyl-sn-glycero-3-phosphate.
Opiranserin (hydrochloride)
Opiranserin (VVZ-149) hydrochloride, a non-opioid and non-NSAID analgesic candidate, is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A), with IC50s of 0.86 and 1.3 μM, respectively. Opiranserin hydrochloride shows antagonistic activity on rP2X3 (IC50=0.87 μM). Opiranserin hydrochloride is development as an injectable agent for the treatment of postoperative pain[1][2][3].
(3s,3as,5ar,6r,9r,9as,9bs)-9-hydroxy-3,5a,9-trimethyl-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3h-naphtho[1,2-b]furan-2-one
(3ar,4r,6s,7r)-7-hydroxy-7-(2-hydroxypropan-2-yl)-1,4-dimethyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,3a,4,5,6,8-hexahydroazulen-2-one
2-[(2r,4as,6s,8r,8ar)-8-hydroxy-4a,8-dimethyl-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydronaphthalen-2-yl]prop-2-enoic acid
(2s)-n-[(2s)-1-(acetyloxy)-3-phenylpropan-2-yl]-2-(benzylamino)-3-phenylpropanimidic acid
(1r,2r,3s,4r,5s,6r)-2,4,6-trihydroxy-3,5-bis[(3-methylbutanoyl)oxy]cyclohexyl 3-methylbut-2-enoate
methyl (1's,3r,4's,4'ar,5'as,10'as)-2-hydroxy-5,6-dimethoxy-1'-methyl-1',3',4',4'a,5',5'a,7',8',10',10'a-decahydrospiro[indole-3,6'-pyrano[3,4-f]indolizine]-4'-carboxylate
alatoside b
{"Ingredient_id": "HBIN015045","Ingredient_name": "alatoside b","Alias": "NA","Ingredient_formula": "C21H34O9","Ingredient_Smile": "CC12CCC(CC1C(CC(C2)OC3C(C(C(C(O3)CO)O)O)O)(C)O)C(=C)C(=O)O","Ingredient_weight": "430.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "839","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101259955","DrugBank_id": "NA"}